Publication of the controversial mutant avian flu papers have hit yet another roadblock. In March, a US advisory panel reversed its prior decision to take out experimental details from two reports about research that seemed to turn the H5N1 bird flu virus into a more virulent and deadly form. Under the original decision, some redacted information would have been available only to accredited researchers.
Office of Strategic Communication